Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. (Q45739449)
Jump to navigation
Jump to search
scientific article published in December 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. |
scientific article published in December 2000 |
Statements
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response (English)
Yang J
Tao Q
Flinn IW
Murray PG
Post LE
Ma H
Piantadosi S
Caligiuri MA
1 December 2000